Efficient iPS cell generation from blood using episomes and HDAC inhibitors

Area of Science:

• Stem Cell Biology
• Epigenetics
• Molecular Biology

Background:

• Generating integration-free human induced pluripotent stem cells (iPSCs) is crucial for safe cell-based therapies.
• Existing methods for iPSC generation can be inefficient or involve integrating vectors.
• Peripheral blood is an accessible source for cell reprogramming.

Purpose of the Study:

• To develop an efficient protocol for generating integration-free iPSCs from peripheral blood.
• To utilize non-integrating episomal plasmids and histone deacetylase (HDAC) inhibitors for enhanced reprogramming.
• To establish a cost-effective and streamlined method for iPSC generation.

Main Methods:

• Peripheral blood mononuclear cells (PBMCs) were isolated and differentiated into erythrocyte progenitors.
• Non-integrating episomal plasmids encoding reprogramming factors (OCT4, SOX2, KLF4, MYCL, LIN28A) and a p53 shRNA were introduced via nucleofection.
• Histone deacetylase (HDAC) inhibitors were added to facilitate epigenetic remodeling.
• Enhanced green fluorescent protein (eGFP) and Epstein-Barr nuclear antigen 1 (EBNA1) expression plasmids were used to monitor transfection and enhance episomal protein expression.

Main Results:

• The protocol efficiently generates integration-free iPSCs from a small volume of peripheral blood.
• The use of HDAC inhibitors increased the generation of fully reprogrammed iPSC colonies by twofold.
• The generated iPSCs exhibited typical human embryonic stem cell (hESC) morphology.

Conclusions:

• This protocol provides an efficient, cost-effective, and non-integrating method for human iPSC generation from peripheral blood.
• The combination of episomal plasmids and HDAC inhibitors significantly enhances the reprogramming process.
• This method holds promise for advancing cell therapy and regenerative medicine applications.